In this case report, an 8-year-old Spitz dog with refractory dermatophytosis showed significant clinical improvement after switching to posaconazole, chosen based on antifungal susceptibility testing, offering a promising treatment option for dogs unresponsive to standard antifungal therapies.
January 2026 in “Preprints.org” In this study, a case of a Spitz dog with refractory dermatophytosis demonstrated marked clinical improvement and complete cure with Posaconazole, highlighting the potential of antifungal susceptibility testing to guide effective treatment in persistent infections unresponsive to standard therapies.
February 2010 in “Journal of The American Academy of Dermatology” This study found that the novel antifungal emulsion NB-002 demonstrated significant antifungal activity and nail clearing in patients with distal subungual onychomycosis involving ≤50% of the nail.
April 2026 in “Ankara Üniversitesi Veteriner Fakültesi Dergisi” This study found that Mueller-Hinton Agar performed better than Dermasel Agar for antifungal susceptibility testing of feline dermatophytes, providing reliable susceptibility data for effective antifungal therapy.
July 2023 in “Zenodo (CERN European Organization for Nuclear Research)” This case report describes a 6-year-old boy with a scalp infection caused by Candida parapsilosis, which was successfully treated with 2% ketoconazole ointment after other treatments failed; antifungal susceptibility testing showed variable drug resistance.